
[Federal Register: June 3, 2008 (Volume 73, Number 107)]
[Notices]               
[Page 31699-31700]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jn08-52]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0306]

 
Preparation for International Cooperation on Cosmetics 
Regulations Meetings in Washington, DC; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
meeting entitled ``International Cooperation on Cosmetics Regulations 
(ICCR)--Preparation for ICCR Meetings in Washington, DC'' to provide 
information and receive comments on the International Cooperation on 
Cosmetics Regulations (ICCR) as well as the upcoming meetings in 
Washington, DC. The topics to be discussed are the topics for 
discussion at the forthcoming ICCR steering committee meeting. The 
purpose of the meeting is to solicit public input prior to the next 
steering committee and expert working group meetings in Washington, DC, 
the week of July 28, 2008, at which the action items from the first 
ICCR meeting are to be discussed.

DATES: The meeting will be held on June 19, 2008, from 3 p.m. to 4:30 
p.m. Send

[[Page 31700]]

registration information and requests to make a presentation by June 
16, 2008.

ADDRESSES: The meeting will be held at 5600 Fishers Lane, 3rd fl., 
Chesapeake Conference Room, Rockville, MD 20857. For security reasons, 
all attendees must preregister 3 days prior to the meeting and are 
asked to arrive no later than 2:50 p.m. because attendees will be 
escorted from the front entrance of 5600 Fishers Lane to the Chesapeake 
Conference Room.
    Comment Submissions: Submit written comments to the Divsion of 
Dockets Management (HFA-305), Food and Drug Administration, 5630 
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments 
to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Tammie Bell, Office of International 
Programs, Food and Drug Administration, 5600 Fishers Lane, Rockville, 
MD 20857, FAX: 301-827-0003, e-mail: Tammie.Bell2@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    The purpose of the multilateral framework on the ICCR is to pave 
the way for the removal of regulatory obstacles to international trade 
while maintaining the highest level of global consumer protection.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from the United States, Japan, the European Union, and 
Canada. These regulatory authority members will enter into constructive 
dialogue with their relevant cosmetics' industry trade associations. 
Currently, the ICCR members are Health Canada; the European Commission 
Directorate General for Enterprise and Industry; the Ministry of 
Health, Labor, and Welfare of Japan; and the U.S. Food and Drug 
Administration. All decisions made by the members of ICCR will be made 
by consensus and will be compatible with the laws, policies, rules, 
regulations, and directives of the respective administrations and 
governments. Members will implement and/or promote actions or documents 
within their own jurisdictions and seek convergence of regulatory 
policies and practices. Successful implementation will require input 
from stakeholders.

II. Registration and Requests for Oral Presentations

    Send registration information (including name, title, firm name, 
address, telephone, and fax number), written material and requests to 
make oral presentations, to the contact person 
(Tammie.Bell2@fda.hhs.gov) (see DATES).
    If you need special accommodations due to a disability, please 
contact Tammie Bell at least 7 days in advance.
    Interested persons may present data, information, or views orally 
or in writing, on issues pending at the public meeting. Oral 
presentations from the public will be scheduled between approximately 4 
p.m. and 4:30 p.m. Time allotted for oral presentations may be limited 
to 10 minutes. Those desiring to make oral presentations should notify 
the contact person (Tammie.Bell2@fda.hhs.gov) (see DATES) and submit a 
brief statement of the general nature of the evidence or arguments they 
wish to present, the names and addresses, phone number, fax, and e-mail 
of proposed participants, and an indication of the approximate time 
requested to make their presentation.

III. Transcripts

    Please be advised that as soon as a transcript is available, it 
will be accessible at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. 
It may be viewed at the Division of Dockets Management (see ADDRESSES). 
A transcript will also be available in either hardcopy or on CD-ROM, 
after submission of a Freedom of Information request. Written requests 
are to be sent to Division of Freedom of Information (HFI-35), Office 
of Management Programs, Food and Drug Administration, 5600 Fishers 
Lane, rm. 6-30, Rockville, MD 20857.

IV. Comments

    Interested persons may submit written or electronic comments to the 
Division of Dockets Management (see ADDRESSES). Submit a single copy of 
electronic comments or two paper copies of any mailed comments, except 
that individuals may submit one paper copy. Comments are to be 
identified with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday.
    Please note that on January 15, 2008, the FDA Division of Dockets 
Management Web site transitioned to the Federal Dockets Management 
System (FDMS). FDMS is a Government-wide, electronic docket management 
system. Electronic comments or submissions will be accepted by FDA only 
through FDMS at http://www.regulations.gov.

V. Electronic Access

    The agenda for the public meeting will be made available via the 
internet at http://www.cfsan.fda.gov/~lrd/vidtel.html

    Dated: May 28, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-12338 Filed 6-2-08; 8:45 am]

BILLING CODE 4160-01-S
